MedTechnology
By
Can Ottai’s New AI Biosensor Reshape Chronic Disease Management for Millions?
AI-powered wearable from Oxford-founded Ottai offers real-time insights, personalized support, and voice-driven healthcare experience Key Takeaways AI-Driven Transformation…
Is Eli Lilly’s $1.3B Acquisition of Verve the Turning Point for CRISPR-Based Cardiovascular Therapies?
Key Highlights Strategic Bet on Early-Stage InnovationEli Lilly’s acquisition of Verve Therapeutics for up to $1.3 billion marks…
Can HekaBio and Alfresa’s AI-Driven Alliance Redefine Japan’s Biopharma Access and Launch Asia’s Next AI Commercialization Engine?
Smart Partnerships: HekaBio Leverages Alfresa’s Scale to Localize Global InnovationJapan’s historically delayed access to global therapies may soon…
Can Ellipsis Health’s $45M Series A and Launch of ‘Sage’ Redefine AI-Driven Care Management in U.S. Healthcare?
Key Insights: Sage Redefines AI Care Management with Empathy at the CoreEllipsis Health is introducing Sage, an emotionally…
At VivaTech 2025, Can NVIDIA, Sanofi, and TetraScience Unlock the Full Potential of Scientific AI Despite a 20-Exabyte Data Barrier?
Key Highlights The 20-Exabyte Problem: Data, Not Models, Is the Limiting FactorAt The Rise of Scientific AI panel…
Will Samsung’s Acquisition of Xealth Spark a New Era of AI-Driven Mobile Healthcare in the U.S.?
Key Highlights Samsung Expands into AI Healthcare with Xealth DealSamsung Electronics has announced its acquisition of Xealth, a…
